Market Place
Sourcing Support
Alchemab appoints Co-Founder Jane Osbourn as Chief Executive Officer
12 Sep 2024 //
PR NEWSWIRE
Alchemab Parkinson`s Antibody Backed By Michael J. Fox Foundation
06 Jun 2024 //
PR NEWSWIRE
Publication in Nature Immunology outlining contribution of B cells to anticancer
15 May 2024 //
PHARMIWEB
Alchemab Therapeutics unveils Alzheimer`s candidate ATLX-1088
22 Jun 2023 //
PR NEWSWIRE
Alchemab Appoints Young T. Kwon as Chief Executive Officer
26 May 2022 //
BUSINESSWIRE
Alchemab Announces Publication of AntiBERTa
19 May 2022 //
BUSINESSWIRE
Alchemab Selected to Access NVIDIA Cambridge-1 Supercomputer
22 Mar 2022 //
BUSINESSWIRE
Alchemab Extends Partnership with Medicines Discovery Catapult
07 Mar 2022 //
BUSINESSWIRE
Alchemab Therapeutics Appoints Young T. Kwon as CFO & COO
15 Nov 2021 //
BUSINESSWIRE
Alchemab Therapeutics Appoints Douglas A. Treco, PhD as Chief Executive Officer
23 Jun 2021 //
BUSINESSWIRE
Alchemab picks up new well-connected CEO
22 Jun 2021 //
FIERCEBIOTECH
Alchemab to collaborate with AstraZeneca on prostate cancer research
05 May 2021 //
PRESS RELEASE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.